abstract |
The invention relates to a method and kit for diagnosing or controlling the treatment of breast cancer in humans. Said method is based upon detection of the presence or absence of at least two different mRNS in a human blood sample, said mRNS coding for various tumour marker proteins EGF-R, CEA, Stanniocalcin, CK20, MAGE-3, GA733.2, MUC1, Her-2/neu, claudin-7 and/or PDGF-β in addition to the presence of mammary carcinoma cells in the blood samples; enabling judgement to be made as to possible metastases. |